Red X iconGreen tick iconYellow tick icon

Angus LindsayResearch Associate Professor
BSc, MSc, PhD

Email angus.lindsay@otago.ac.nz

As Principal Investigator of The Neurology of Myopathies (NoM) Lab, Associate Professor Lindsay and his team conducts preclinical research focused on developing pharmaceutical and gene editing therapies for neuromuscular diseases, with a primary emphasis on muscular dystrophies, particularly Duchenne.

The NoM Lab’s work spans a broad spectrum of fundamental and translational biology, integrating physiology, neurology, behaviour, molecular biology, biochemistry, bio-imaging, and biomechanics.

Key research priorities include developing innovative therapeutics to stabilise skeletal muscle, uncovering mechanisms underlying neurological dysfunction, refining treatment dosing strategies, and advancing evaluation techniques to accelerate translation from preclinical studies to clinical application.

The NoM Lab has research collaborations across New Zealand and with international programs in Australia, France, Singapore, UK and the USA. Associate Professor Lindsay also facilitates and consults on therapeutic advancement to help bring clinical trials to New Zealand, ensuring patients have access to globally advanced treatments.

Beyond the science, the NoM Lab is committed to patient advocacy and community engagement through partnerships with organisations in New Zealand and internationally.

Current roles

  • Research Associate Professor in Medicine
  • Principal Investigator of the Neurology of Myopathies (NoM) Lab
  • Scientific Advisor for the Muscular Dystrophy Association of New Zealand
  • Neuromuscular Research Foundation Trust Chairperson

Positions and memberships

  • Rare disorders researchers’ network – Rare Disorders New Zealand
  • World Muscle Society
  • Australasian Neuromuscular Network
  • New Zealand Physiological Society

Publications

Fallon, K. S., Southern, W. M., Lindsay, A., Powers, J. X., Cavazos, C. L., Rodney, G. G., … Ervasti, J. M. (2026). Redox-sensitive eccentric contraction-induced force loss in a muscle-specific Actb knockout myopathy model. Skeletal Muscle. Advance online publication. doi: 10.1186/s13395-026-00443-4 Journal - Research Article

Merry, D., Devananthan, P., Craven, R., Joe, K., Major, G., Chen, J., Kabaliuk, N., & Lindsay, A. (2026). Dystrophin-deficient skeletal muscle is further stiffened by contraction-induced injury but is resilient to isometric fatigue. Neuromuscular Disorders, 67(Suppl. 1), 2.69eP. doi: 10.1016/j.nmd.2026.106863 Conference Contribution - Published proceedings: Abstract

Lindsay, A., Major, G., Eliades, J., Chen, J., & Najt, C. (2026). Endocrine-associated decoupling of pancreatic function drives glucose intolerance in the mdx mouse model of Duchenne muscular dystrophy. Neuromuscular Disorders, 67(Suppl. 1), 2.95P. doi: 10.1016/j.nmd.2026.106873 Conference Contribution - Published proceedings: Abstract

Major, G. S., Chen, J., van den Berg, E., Merry, D. L., & Lindsay, A. (2026). Regimen-dependent glucocorticoid effects improve muscle performance without altering CNS physiology in mdx mice. Journal of Physiology. Advance online publication. doi: 10.1113/jp291378 Journal - Research Article

Merry, D. L., Devananthan, P., Kabaliuk, N., & Lindsay, A. (2026). Viscoelastic properties of dystrophin-deficient mouse skeletal muscles are resilient to isometric fatiguing exercise. Physiological Reports, 14(6), e70841. doi: 10.14814/phy2.70841 Journal - Research Article

Back to top